- Home
- Daily Diary
- Asset Class
- Sector
- Latest
- Author
- Street Notes
- TheStreet
- Switch to
- Premium Tools
- Real Money
- Real Money Pro
- Action Alerts PLUS
- Stocks Under $10
- Breakout Stocks
- Options Profits
Latest Commentary
Real Money: Independent market insight from a veteran team of trusted Wall Street pros.
• Up-to-the-minute reports on market activity
• Actionable trade ideas
• Up-to-the-minute reports on market activity
• Actionable trade ideas
Latest Strategies
Real Money Pro: Professional tools and specific trade ideas for active investors.
• Information-packed market flow providing trade ideas, fast
• Dynamic interface with professional-grade analytical tools
• Full, unlimited access to Real Money
• Information-packed market flow providing trade ideas, fast
• Dynamic interface with professional-grade analytical tools
• Full, unlimited access to Real Money
Latest Alert
May 24, 2013 | 06:41 PM EDT
We remain overweight in industrials, materials, energy and financials. FULL ALERT »
Action Alerts PLUS: Jim Cramer and Stephanie Link actively manage a real money portfolio for Jim's charitable trust.
• Timely trade alerts including price targets
• Unique insight into market movements
• Guidance on how to trade right alongside Jim and Stephanie
• Timely trade alerts including price targets
• Unique insight into market movements
• Guidance on how to trade right alongside Jim and Stephanie
Latest Alert
May 24, 2013 | 04:28 PM EDT
As stocks ended their four-week winning streak this week, we used the volatility to trim one model portfolio position. FULL ALERT »
Stocks Under $10: David Peltier manages a portfolio of affordable stocks with huge upside potential.
• Identify fast-growing small-cap stock opportunities
• Buy and sell alerts allow you to analyze overlooked opportunities quickly
• In-depth reports and research packed with proprietary analysis
• Identify fast-growing small-cap stock opportunities
• Buy and sell alerts allow you to analyze overlooked opportunities quickly
• In-depth reports and research packed with proprietary analysis
Latest Alert
May 24, 2013 | 08:41 AM EDT
This name issued a near-perfect fiscal third-quarter earnings report and bumped its full-year guidance higher. FULL ALERT »
Breakout Stocks: Bryan Ashenberg, CFA, manages a portfolio of small and mid-cap stocks with high growth potential.
• Identify industry-changing macrotrends in their infancy
• Timely trade alerts loaded with detailed research
• Frequent communication about all Bryan's portfolio holdings
• Identify industry-changing macrotrends in their infancy
• Timely trade alerts loaded with detailed research
• Frequent communication about all Bryan's portfolio holdings
Latest Commentary
Options Profits: Day in and day out, our team of professional options traders search for inventive plays for trading spikes in market activity, emerging trends, and breaking news and events. These veterans reveal all their charts and technical data — delivering daily strategies and insightful commentary written specifically for the options trader plus 40 options trade ideas per week!
Pfizer Inc (PFE)
PFE (NYSE:Drugs)
$29.04
-0.07
-0.24%
Today's Range: 28.68 - 29.11 |
PFE Avg Daily Volume: 33,681,500
| Last Update: 05/24/13 - 4:00 PM EDT |
| Volume: 35,079,163 |
| YTD Performance: 15.79% |
| Open: $28.91 |
| Previous Close: $29.11 |
| 52 Week Range: $21.40 - $31.15 |
| Oustanding Shares: 7,093,223,330 |
| Market Cap: 206,483,731,136 |
Analysts Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Strong Buy | 11 | 12 | 12 | 12 |
| Moderate Buy | 2 | 2 | 2 | 2 |
| Hold | 1 | 2 | 2 | 2 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.25 | 1.34 | 1.34 | 1.34 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $0.56 | $0.55 | $2.22 | $2.34 |
| Number of Analysts | 5 | 5 | 8 | 7 |
| High Estimate | $0.58 | $0.57 | $2.27 | $2.45 |
| Low Estimate | $0.55 | $0.53 | $2.16 | $2.19 |
| Prior Year | $0.62 | $0.53 | $2.19 | $2.22 |
| Growth Rate (Year over Year) | -9.03% | 3.02% | 1.43% | 5.54% |
chriskatje: Stock articles this weekend $CSTR $PFE $ZTS $CPB $GME $LGF and an early look at Noodles and Company IPO #Stocks #IPO
3 hours ago from web
3 hours ago from web
StockSignaling: Range/Volume Advances: $SHLD $ORIG $FLTX $PG $VVTV $HPQ $GAME $RL $DOV $LPS $AEO $I $JAZZ $KND $PFE http://t.co/Vtx6dLy0Nw #nasdaq #trading
5 hours ago from Stock Signaling
5 hours ago from Stock Signaling
DewDiligence: Selling $ZTS in order to reacquire it more cheaply in the $PFE swap is a bad idea for 2 reasons: http://t.co/2zdEBLqq9V
12 hours ago from web
12 hours ago from web
ashishmali28: RT @BioPharmaJosh: What a week, another heavyweight fight in India: $PFE vs. India Pharmaceutical Alliance ... http://t.co/fa8nG6jmxN
13 hours ago from Twitter for BlackBerry®
13 hours ago from Twitter for BlackBerry®
BioPharmaJosh: What a week, another heavyweight fight in India: $PFE vs. India Pharmaceutical Alliance ... http://t.co/fa8nG6jmxN
13 hours ago from HootSuite
13 hours ago from HootSuite
HoroscopeOfUSA: RT @RCP_2013: The #RobinsonHealthCareIndex
$IYH 103.05
$IXJ 78.10
$CI 67.57
$MRK 46.99
$AET 59.90
$PFE 29.05
$AZN 52.12
$IHI 79.47
$IHE 102.68
$HUM 79.40
13 hours ago from web
13 hours ago from web
OneChicago: $PFE Jul EFP: (-43) basis point offer. Reduce your margin loan expense: Negative rates mean you get paid. http://t.co/cHmp6cUgnU
14 hours ago from OneChicagoFeed
14 hours ago from OneChicagoFeed
Sandman7591: $ATRS tryin to push move highs.. $PFE initiates liquid advil trials this month. may result in milestone for $ATRS if that's the project
15 hours ago from TweetDeck
15 hours ago from TweetDeck
sindap: Spin-offs are very different than split-offs. Just look at the $PFE and $ZTE transaction. @Lexcolumn http://t.co/zytlajYdHo via @FT
16 hours ago from Tweet Button
16 hours ago from Tweet Button
How much to buy?
Here are seven reasons why.
A move below 1575 on the S&P 500 would be a signal to go short.
Focusing on near-term drug stock earnings is the wrong move.
Pfizer estimates reduced at UBS
PFE earnings estimates were reduced to reflect the impact of FX, said UBS.
PFE Investor Mtg.
Pfizer Annual Shareholder Meeting - 8:30AM
It’s the only thing that explains today’s action.
These name capitalize on the trend of spending on our pets, which has become recession proof.
Jim Cramer looks at why he is highlighting pharma along with growth biotech, with Nicole Urken, Mad Money Research Associate.
The recent stock pullback is making dividend yields for Procter & Gamble, Pfizer and Bank of America, more attractive. Portfolio Manager David Peltier expects to see more payout increases this spring.
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.
TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.
IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.
TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.
IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.
© 2013 TheStreet, Inc. All rights reserved.